Page 6 - Ichnos Sciences News Today

BioSpectrum is an integrated B2B media platform for the healthcare and bioscience industry in India and Asia.

As the year comes to an end, biopharma and life sciences companies are strengthening their leadership teams and boards with the latest round of Movers & Shakers.

/PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative biologics in oncology, today presented preclinical data that support...

/PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative biologics in oncology, today presented preclinical data that support...

Former FDA head Stephen Hahn is adding a new title to his role at Flagship Pioneering: CEO of the incubator's blood cancer test startup Harbinger Health. Takeda's oncology leader Rachael Brake heads to Corbus as chief scientific officer charged with redefining scope of early-stage pipeline. Goldfinch Bio snags 13-year Ardelyx vet as CSO.

BioSpace Movers & Shakers, Dec. 10 - read this article along with other careers information, tips and advice on BioSpace

Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.

/PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative biologics in oncology and autoimmune diseases, today presented...

Published: Jun 03, 2021 By Alex Keown 180 Life Sciences -- Russell T. Ray and Teresa DeLuca were appointed to the board of directors of 180 Life Sciences. Ray was formerly Managing Director and co-Head of Global Health Care at Credit Suisse First Boston Corporation. More recently, Ray was a Partner and Senior Advisor to HLM Venture Partners, a health care-focused venture capital firm. He currently serves on the board of directors of Merrimack Pharmaceuticals, Inc. DeLuca comes to 180 Li...

/PRNewswire/ -- Kallyope Inc., a leading biotechnology company focused on identifying and pursuing therapeutic opportunities involving the gut-brain axis,...